Literature DB >> 18351301

The antioxidative activity of riboflavin in the presence of antipyrin. Spectroscopic studies.

Mariana Voicescu1, Gabriela Ionita, Adrian Beteringhe, Marilena Vasilescu, Aurelia Meghea.   

Abstract

The effect of Antipyrin upon the antioxidant activity of the riboflavin has been evidenced using chemiluminescent system luminol-hydrogen peroxide, in Tris-HCl buffer, pH 8.5. It was found that riboflavin antioxidant activity depends on the reaction time and the Antipyrin concentration. Using ESR spectroscopy the hydroxyl radical generation, in the mentioned chemiluminescent system, was evidenced. The interaction between reactants was also investigated by UV-VIS and fluorescence spectroscopy. The effect of Antipyrin concentration upon the riboflavin fluorescence has also been investigated. The fluorescence quenching by Antipyrin is not significant and subsequently the riboflavin fluorescence quenching doesn't indicate an electron transfer process through diffusion-controlled mechanism. The results are discussed with relevance to the redox processes of riboflavin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18351301     DOI: 10.1007/s10895-008-0354-x

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  10 in total

1.  Introduction and General Overview of Cyclodextrin Chemistry.

Authors:  József Szejtli
Journal:  Chem Rev       Date:  1998-07-30       Impact factor: 60.622

2.  BIODYNAMICS OF THIOUREA-ALKALOID COMBINATIONS.

Authors:  P W RAGOZZINO; M H MALONE
Journal:  J Pharmacol Exp Ther       Date:  1963-09       Impact factor: 4.030

Review 3.  Drugs and the liver. Part II. The role of the antipyrine test in drug metabolism studies.

Authors:  M Hartleb
Journal:  Biopharm Drug Dispos       Date:  1991-11       Impact factor: 1.627

Review 4.  Two interconnected B vitamins: riboflavin and pyridoxine.

Authors:  D B McCormick
Journal:  Physiol Rev       Date:  1989-10       Impact factor: 37.312

5.  Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.

Authors:  M Danhof; A van Zuilen; J K Boeijinga; D D Breimer
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

6.  Inhibition of human neutrophil oxidative burst by pyrazolone derivatives.

Authors:  David Costa; Alexandra P Marques; Rui L Reis; José L F C Lima; Eduarda Fernandes
Journal:  Free Radic Biol Med       Date:  2005-10-21       Impact factor: 7.376

Review 7.  Quantifying hepatic function in the presence of liver disease with phenazone (antipyrine) and its metabolites.

Authors:  J V St Peter; W M Awni
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

Review 8.  The role of molecular modeling in bionanotechnology.

Authors:  Deyu Lu; Aleksei Aksimentiev; Amy Y Shih; Eduardo Cruz-Chu; Peter L Freddolino; Anton Arkhipov; Klaus Schulten
Journal:  Phys Biol       Date:  2006-02-02       Impact factor: 2.583

9.  Human metabolism of antipyrine labelled with 14C in the pyrazolone ring or in the N-methyl group.

Authors:  H Uchino; T Inaba; W Kalow
Journal:  Xenobiotica       Date:  1983-03       Impact factor: 1.908

Review 10.  Vitamin C as an antioxidant: evaluation of its role in disease prevention.

Authors:  Sebastian J Padayatty; Arie Katz; Yaohui Wang; Peter Eck; Oran Kwon; Je-Hyuk Lee; Shenglin Chen; Christopher Corpe; Anand Dutta; Sudhir K Dutta; Mark Levine
Journal:  J Am Coll Nutr       Date:  2003-02       Impact factor: 3.169

  10 in total
  2 in total

1.  Physicochemical and Antioxidant Properties of Riboflavin in Dextran70/HSA Systems.

Authors:  Mariana Voicescu; Sorana Ionescu; Cecilia Lete
Journal:  J Fluoresc       Date:  2018-06-26       Impact factor: 2.217

2.  Fluorescent Flavin/PVP-Coated Silver Nanoparticles: Design and Biological Performance.

Authors:  Mariana Voicescu; Oana Craciunescu; Jose M Calderon-Moreno; Mihai Anastasescu; Vasile S Manoiu; Rodica Tatia; Daniela C Culita; Lucia Moldovan
Journal:  J Fluoresc       Date:  2022-04-01       Impact factor: 2.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.